COST EFFECTIVENESS OF ANTI-PD-1/PD-L1 TREATMENTS: SYSTEMATIC REVIEW OF PUBLISHED STUDIES

被引：0
|
作者：
Aggarwal, S. [1 ]
Topaloglu, O. [1 ]
Kumar, S. [2 ]
机构：
[1] NOVEL Hlth Strategies, Chevy Chase, MD USA
[2] Inst Global Policy, Washington, DC USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.187
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN110
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Pneumonitis with anti-PD-1/PD-L1 therapy
    Naidoo, J.
    Cunningham, J.
    Woo, K. M.
    Hellmann, M. D.
    Postow, M. A.
    Drilon, A. E.
    Chaft, J. E.
    Lesokhin, A. M.
    Segal, N. H.
    Callahan, M. K.
    Rudin, C. M.
    Iyriboz, T.
    Wolchok, J. D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S103 - S103
  • [2] Impact of PD-L1 feedback modulation on the sensitivity of anti-PD-1/PD-L1
    Zhu, Jian
    Zhu, Rebecca L.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review
    Zhang, Yiru
    Yao, Qigu
    Pan, Yong
    Fang, Xinru
    Xu, Haoying
    Zhao, Tingxiao
    Zhu, Guangqi
    Jiang, Tianan
    Li, Shibo
    Cao, Hongcui
    CANCERS, 2023, 15 (03)
  • [4] Parameters of Tumor Microenvironment Determine Effectiveness of Anti-PD-1/PD-L1 Therapy
    Tashireva, Liubov A.
    Muravyova, Dariya T.
    Popova, Natalya O.
    Goldberg, Victor E.
    Vtorushin, Sergey V.
    Perelmuter, Vladimir M.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (11) : 1461 - 1468
  • [5] Parameters of Tumor Microenvironment Determine Effectiveness of Anti-PD-1/PD-L1 Therapy
    Liubov A. Tashireva
    Dariya T. Muravyova
    Natalya O. Popova
    Victor E. Goldberg
    Sergey V. Vtorushin
    Vladimir M. Perelmuter
    Biochemistry (Moscow), 2021, 86 : 1461 - 1468
  • [6] The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
    Sui, Xinbing
    Ma, Junhong
    Han, Weidong
    Wang, Xian
    Fang, Yong
    Li, Da
    Pan, Hongming
    Zhang, Li
    ONCOTARGET, 2015, 6 (23) : 19393 - 19404
  • [7] Pneumonitis From Anti-PD-1/PD-L1 Therapy
    Balaji, Aanika
    Verde, Franco
    Suresh, Karthik
    Naidoo, Jarushka
    ONCOLOGY-NEW YORK, 2017, 31 (10): : 739 - +
  • [8] Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
    Liu, Haoran
    Ye, Tao
    Yang, Xiaoqi
    Lv, Peng
    Wu, Xiaoliang
    Thou, Hui
    Lu, Hongyan
    Tang, Kun
    Ye, Zhangqun
    DISEASE MARKERS, 2020, 2020
  • [9] the Effect of aberrant N-glycosylation of PD-L1 on the potency of anti-PD-1 treatments
    Kaufman, Bar
    Erlichman, Nofar
    Meshel, Tsipi
    Ben-Baruch, Adit
    Elkabets, Moshe
    Porgador, Angel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 787 - 787
  • [10] PREDICTIVE AND PROGNOSTIC ROLE OF PD-L1 IN UROTHELIAL CARCINOMA PATIENTS WITH ANTI-PD-1/PD-L1 THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tang, Kun
    Jiang, Kehua
    Zhou, Hui
    Liu, Haoran
    Ye, Zhangqun
    Xu, Hua
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1040 - E1040
12345